Cotadutide, but not liraglutide improved hepatic parameters and metabolic dysfunction-associated steatohepatitis (MASH) with similar weight loss with 200 g cotadutide compared to 1.8 mg liraglutide and greater with 300 g cotadutide versus 1.8 mg liraglutide [47]
D., Wharton, S., Yokote, K., Zeuthen, N., & Kushner, R
Nonetheless, there is still some controversy on the in vivo involvement of FFAR2 and FFAR3 in GLP-1 modulation (301, 302), with some reports indicating that blockade of GPR43 in vitro releases GLP-1 (303) and others indicating different mechanisms of action, with FFAR2 releasing PYY from intestinal L-cells (81), while FFAR3 restricted to submucosal neuronal activity (295) despite its apparent expression by the majority of enteroendocrine cells (83)
Retatrutide has also exhibited positive effects on appetite regulation, leading to decreased calorie intake and improved eating habits
En cas de traitements mdicamenteux, demander conseil un professionnel de sant
Glycemic Control: Researching how triple agonism provides a more robust model for glucose regulation compared to single or dual agonists
